IBAC

IB Acquisition Corp.
—

Company Information

Company Name
IB Acquisition Corp.
CIK
CIK0001998781
Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ticker: Exchange
IBAC: Nasdaq, IBACR: Nasdaq
Fiscal Year End
September 30
Owner Organization
08 Industrial Applications and Services
SIC
8731
SIC Description
Services-Commercial Physical & Biological Research
Ticker
IBAC

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
2026-03-23
Shares purchased (TTM)
0
Shares sold (TTM)
764,619
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
37,347
Shares outstanding
759,139
Ownership
4.92%
-87.66% Y/Y

Earnings Market Reaction

Filing date
2026-08-14
Price on filing date
—
1-month reaction
0.00%
3-month reaction
…
Drift continued7/9 (78%)
Faded / reversed2/9 (22%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value0000011112
Restricted Cash Current---1------
Other Prepaid Expense Current0000000000
Prepaid Insurance000-00000-
Prepaid Taxes000-------
Assets Current0001111112
Prepaid Expense Noncurrent--------0-
Assets Held In Trust Noncurrent881616122120120119117116
Assets981617122121121120118117
Accrued Liabilities Current--------00
Liabilities Current
Accounts Payable And Accrued Liabilities Current11000000--
Taxes Payable Current---110110-
Notes Payable Current1-----0---
Other Liabilities Current000000----
Liabilities Current-212101100
Liabilities2212101100
Temporary Equity Carrying Amount Attributable To Parent881616121120119118117116
Stockholders Equity
Common Stock Value0000000000
Retained Earnings Accumulated Deficit-2-2-1-111111-0
Stockholders Equity-2-2-1-1111111
Additional Paid In Capital--------02
Liabilities And Stockholders Equity981617122121121120118117
Temporary Equity Shares Authorized1111121212121212
Temporary Equity Redemption Price Per Share11.0410.9710.8010.7210.5210.4410.3510.2610.1510.05
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized10101010101010101010
Preferred Stock Shares Issued0000000000
Preferred Stock Shares Outstanding0000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized100100100100100100100100100100
Common Stock Shares Issued4444444444
Shares Outstanding4444444444

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

IB Acquisition Corp. (IBAC) — SEC Financial Statements & Analysis

IB Acquisition Corp. (IBAC) is a services-commercial physical & biological research company, incorporated in NV. IB Acquisition Corp. trades on Nasdaq as: IBAC, IBACR. IB Acquisition Corp. (IBAC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, IB Acquisition Corp. carries a market cap of $8.18M, a P/E ratio of -20.48x, a P/B ratio of -3.54x, an enterprise value of $8.65M, and an EV/EBITDA multiple of -4.84x. On profitability, it posts a Return on Equity (ROE) of 46.67%, a Return on Assets (ROA) of -0.61%, and a Return on Invested Capital (ROIC) of -224.68%. Per share, it reports EPS of $-0.53, diluted EPS of $-0.53, free cash flow per share of $-2.43, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -111.42% year-over-year and EPS growth of -273.02% year-over-year. On the balance sheet, it maintains a current ratio of 0.16x, a quick ratio of 0.16x, working capital of $-1.55M, a debt-to-equity ratio of -1.09x, a debt ratio of 0.22, an interest coverage ratio of -0.50x, free cash flow of $-1.85M (TTM), and net debt of $469.84K. Figures sourced from SEC EDGAR.

Market Cap
$8.18M
P/E TTM
-20.48x
EPS TTM
$-0.53
P/B TTM
-3.54x
ROE TTM
46.67%
ROA TTM
-0.61%
Debt To Equity
-1.09x
Free Cash Flow TTM
$-1.85M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IB Acquisition Corp. in?

IB Acquisition Corp. (IBAC) operates in the Services-Commercial Physical & Biological Research industry.

What exchange does IBAC trade on?

IB Acquisition Corp. (IBAC) trades on the Nasdaq.

Where is IB Acquisition Corp. incorporated?

IB Acquisition Corp. is incorporated in NV.

When was IB Acquisition Corp. (IBAC)'s most recent SEC filing?

IB Acquisition Corp. (IBAC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.

What is IBAC's market cap?

IB Acquisition Corp. (IBAC) has a market capitalization of $8.18M as of 2026-06-30.

What is IBAC's EPS (earnings per share)?

IB Acquisition Corp. (IBAC)'s trailing twelve month EPS is $-0.53 as of 2026-06-30.

What is IBAC's ROE (return on equity)?

IB Acquisition Corp. (IBAC)'s trailing twelve month Return on Equity (ROE) is 46.67% as of 2026-06-30.

What is IBAC's ROA (return on assets)?

IB Acquisition Corp. (IBAC)'s trailing twelve month Return on Assets (ROA) is -0.61% as of 2026-06-30.

What is IBAC's ROIC (return on invested capital)?

IB Acquisition Corp. (IBAC)'s trailing twelve month Return on Invested Capital (ROIC) is -224.68% as of 2025-06-30.

What is IBAC's EV/EBITDA?

IB Acquisition Corp. (IBAC)'s trailing twelve month EV/EBITDA is -4.84x as of 2026-06-30.

Wall Street's data.
Main Street's price.